Article

Dermis fat graft: neglected in management of socket problems?

Dermis fat grafts have become "overlooked" as orbital implants in favor of newer alternatives but deserve to maintain a role in primary and secondary socket implant procedures, and more complex socket problems, said James A. Katowitz, MD, Children's Hospital of Philadelphia.

New Orleans-Dermis fat grafts have become "overlooked" as orbital implants in favor of newer alternatives but deserve to maintain a role in primary and secondary socket implant procedures, and more complex socket problems, said James A. Katowitz, MD, Children's Hospital of Philadelphia.

Dr. Katowitz outlined uses for dermis fat grafts at a combined meeting of the American Academy of Ophthalmology and the American Society of Ocularists.

Dermis fat grafts may be particularly beneficial for children, since the implants will increase in size as a child grows. Conditions for which they might be used as a primary implant include congenital microphthalmia or after enucleation, while as a secondary implant fat grafts could be used to cover exposure problems with the primary implant or in cases of an infected integrated implant, Dr. Katowitz said.

Fat grafts may also be used to treat complex socket problems such as infection or necrosis or following radiation and enucleation related to retinoblastoma treatment. In the latter case, the assistance of craniofacial surgeons is important to appropriately address all aspects of the case, Dr. Katowitz recommended.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.